2023年6月7日,

LEADOPTIK——硅谷的医学成像公司宣布它已经筹集了500万美元的超额认购系列种子资金由从SOSV MetaVC与参与合作,索尼的创新基金,TSVC, ENEA,乔·(Dropbox的创始人之一),雷在拨弄(确定)的创始人之一,和其他人。这一轮融资将使LEADOPTIK搬到产品开发的下一阶段——包括FDA的批准,在商业化之路。该公司正在开发一种小型成像系统进入了一个新的水平人类肺部深处的实时成像,使癌症的早期诊断。并结合小说纳米制造和创新的光学超材料技术,公司的产品将允许外科医生视图对象五十次小于什么是可能的与现有成像系统。利用专有的光学介质metasurfaces, LEADOPTIK缩小光学元素大小类似的人类头发。,由于其前所未有的体积小,由先进的成像软件,探测器可以通过旅行即使最窄的航空公司,使实时成像和检测微小的肿瘤。此外,LEADOPTIK小形式的调查与活检针,允许其集成期间提供实时指导活检程序。这种集成提高活检的准确性至关重要,往往盲目地执行。据世界卫生组织统计,肺癌著称的负责全世界最高的癌症相关的死亡人数。和早期发现和诊断病人的生存是至关重要的; however, there are currently no effective approaches for diagnosing cancer at its earliest stages. KEY QUOTES: “As a technical CEO, I feel incredibly fortunate to witness how my work on metasurface technology has the potential to enhance people’s health. This funding is a very encouraging step to get us closer to that goal.” — Reza Khorasaninejad, co-founder and CEO of LEADOPTIK “I am thrilled to be part of this exciting journey and grateful for the support of visionary investors who are helping us bring the true benefits of this cutting-edge technology to patients.” — Jiang You, co-founder of LEADOPTIK “We look for exciting investment opportunities like LEADOPTIK, where breakthroughs are being made with novel solutions like optical metamaterials.” — Conrad Burke, managing partner at MetaVC Partners “We believe that such technology innovation has the potential to transform healthcare, particularly in areas such as cancer diagnostics, where there is a large unmet need for more accurate and timely screening and diagnosis. The work that LEADOPTIK is doing in developing novel imaging technologies to address lung cancer detection is a perfect example of that.” — Austin Noronha, Managing Director-US, Sony Ventures Trending on Pulse 2.0